| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/16/1997 | US5698680 Antibodies specific for lipopolysaccharide binding protein |
| 12/16/1997 | US5698677 Stable preparation for the treatment of blood coagulation disorders |
| 12/16/1997 | US5698672 Synthetic calcitonin mimetics |
| 12/16/1997 | US5698671 Metalloproteinase peptides |
| 12/16/1997 | US5698670 Aureobasidins |
| 12/16/1997 | US5698669 Tri-arginine insulins |
| 12/16/1997 | US5698594 Treatment and prevention of risk factors for cardiovascular diseases |
| 12/16/1997 | US5698583 Oligoelements and phospholipase A2 immuno-enhancer compositions, preparation thereof, and use thereof |
| 12/16/1997 | US5698569 Viricide |
| 12/16/1997 | US5698530 A vaccinia virus into which carcinoembryonic antigen gene is inserteted; induce an active immune response |
| 12/16/1997 | US5698525 Controlling carbohydrate, protein ratio |
| 12/16/1997 | US5698523 Acylated enol derivatives as prodrugs of elastase inhibitors |
| 12/16/1997 | US5698522 6-position modified decapeptide LHRH antagonists |
| 12/16/1997 | US5698521 Native calcitonin mimetics |
| 12/16/1997 | US5698520 Peptide related to human programmed cell death and DNA encoding the same |
| 12/16/1997 | US5698519 Polypeptide specifically inhibiting cathepsin L |
| 12/16/1997 | US5698518 Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists |
| 12/16/1997 | US5698517 Thyroxin-binding HSA fragments |
| 12/16/1997 | US5698516 Biologically active vasopressin analogues |
| 12/16/1997 | US5698515 Insulin-containing polymer composition for oral administration |
| 12/16/1997 | US5698449 Synthetic peptide and its uses |
| 12/16/1997 | US5698445 Human PAK65 |
| 12/16/1997 | US5698444 Isolated amino acid compound |
| 12/16/1997 | US5698442 DNA encoding an 18 Kd CDK6 inhibiting protein |
| 12/16/1997 | US5698439 Novel malignant cell type markers of the interior nuclear matrix |
| 12/16/1997 | US5698438 Bacterial hemoglobin receptor gene |
| 12/16/1997 | US5698436 Introduction and expression of foreign genetic material in epithelial cells |
| 12/16/1997 | US5698435 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 12/16/1997 | US5698428 Human PAK65 |
| 12/16/1997 | US5698419 Formed by fusion of cells from mouse myeloma line and spleen cells from mouse previously immunized with cachectin-tumor necrosis factor |
| 12/16/1997 | US5698417 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 12/16/1997 | US5698405 Coupling immunogenic agent with a carbohydrate polymer |
| 12/16/1997 | US5698404 Method of predicting fetal membrane rupture based on pro-matrix metalloproteinase-9 (pro-mmp-9) |
| 12/16/1997 | US5698403 Methods of detecting platelet-activating factor acetylhydrolase using antibodies |
| 12/16/1997 | US5698396 Method for identifying auto-immunoreactive substances from a subject |
| 12/16/1997 | US5698389 Polypeptides |
| 12/16/1997 | US5698232 Pharmaceutical composition for treatment of sudden deafness |
| 12/16/1997 | US5698219 Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof |
| 12/16/1997 | US5698204 Polypeptides |
| 12/16/1997 | US5698202 Deletion of e-1 gene and replacement with cytomegalovirus promoter sequence which controls the expression of dna coding for a rabies virus protein useful in single-dose rabies vaccines, also partial deletion of e-3 gene |
| 12/16/1997 | US5698201 Method for treatment of antigenically modified polypeptides |
| 12/16/1997 | US5698198 Method for treating gram negative bacterial infections in humans |
| 12/16/1997 | US5698197 Monoclonal antibody specific for advanced glycosylation endproducts in biological samples |
| 12/16/1997 | US5698196 Antibodies specific for neutrophic chemotactic factor |
| 12/16/1997 | US5698195 Administering chimeric antibody comprising non-human variable region or tumor necrosis factor antigen-binding portion thereof and human constant region |
| 12/16/1997 | US5698194 Method for making a medicament for treating secondary immunodeficiency |
| 12/16/1997 | US5698193 Method of treating birds |
| 12/16/1997 | US5698184 Compositions and methods for skin tanning and protection |
| 12/16/1997 | US5698178 Binding a multidrug transporter protein and an antigen associated with a tumor or infectious agent |
| 12/16/1997 | CA2058441C Crystalline r-h-gm-csf and method for the preparation |
| 12/16/1997 | CA1339583C Monoclonal antibody nuh2 capable of inactivating motility of human sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen |
| 12/13/1997 | CA2206192A1 Modulation of lc132 (opioid-like) receptor function |
| 12/11/1997 | WO1997046884A1 Materials and methods for detection of breast cancer |
| 12/11/1997 | WO1997046697A3 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 12/11/1997 | WO1997046697A2 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 12/11/1997 | WO1997046688A1 Lipid kinase |
| 12/11/1997 | WO1997046686A2 Tumor necrosis factor-related polypeptide |
| 12/11/1997 | WO1997046685A1 Polynucleotides encoding secreted proteins from human dendritic cells |
| 12/11/1997 | WO1997046684A1 Non-activated receptor complex proteins and uses thereof |
| 12/11/1997 | WO1997046683A2 Polynucleotides encoding secreted proteins |
| 12/11/1997 | WO1997046682A2 Polynucleotides from human adult pbmc encoding secreted proteins |
| 12/11/1997 | WO1997046681A2 GALANIN RECEPTOR GalR2 |
| 12/11/1997 | WO1997046679A1 Cyclin-c variants, and diagnostic and therapeutic uses thereof |
| 12/11/1997 | WO1997046678A1 Nucleic acids and polypeptides related to presenilin |
| 12/11/1997 | WO1997046677A1 PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO |
| 12/11/1997 | WO1997046676A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides |
| 12/11/1997 | WO1997046675A1 Metabotropic gaba[b] receptors, receptor-specific ligands and their uses |
| 12/11/1997 | WO1997046673A2 Inhibition of hiv-1 replication by antisense rna expression |
| 12/11/1997 | WO1997046672A2 Antisense nucleic acids and hammerhead ribozymes |
| 12/11/1997 | WO1997046671A1 Enhanced efficacy of liposomal antisense delivery |
| 12/11/1997 | WO1997046669A1 Transgenic mammals lacking expression of amylin |
| 12/11/1997 | WO1997046668A1 Novel peptide, process for the production of the same, and use of the same |
| 12/11/1997 | WO1997046663A1 Interleukin-1 beta converting enzyme like apoptotic protease-6 |
| 12/11/1997 | WO1997046662A1 Interleukin-1 beta converting enzyme like apoptotic protease-7 |
| 12/11/1997 | WO1997046661A2 A human radioresistance/cell cycle progression gene |
| 12/11/1997 | WO1997046589A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 12/11/1997 | WO1997046587A2 Ob PROTEIN BINDING PROTEIN |
| 12/11/1997 | WO1997046586A1 Novel human receptor type tyrosine kinase-like protein |
| 12/11/1997 | WO1997046585A2 Fragments of leptin (ob protein) |
| 12/11/1997 | WO1997046584A1 Exendin analogues, processes for their preparation and medicaments containing them |
| 12/11/1997 | WO1997046583A1 Novel feline cytokine protein |
| 12/11/1997 | WO1997046582A1 Meningococcal vaccine |
| 12/11/1997 | WO1997046581A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 12/11/1997 | WO1997046580A1 Antibiotic producing microbe |
| 12/11/1997 | WO1997046579A1 Neuropeptide y agonists |
| 12/11/1997 | WO1997046578A1 Peptide derivatives |
| 12/11/1997 | WO1997046576A1 Anticoagulant peptidyl-arginine aldehyde derivatives |
| 12/11/1997 | WO1997046575A1 Method of isolating cyclosporins |
| 12/11/1997 | WO1997046573A1 Method of inhibiting antigen processing, chimeric proteins reflecting this method, and methods of expressing those proteins |
| 12/11/1997 | WO1997046571A1 Phosphorothioate oligonucleotides that bind to the v3-loop and uses thereof |
| 12/11/1997 | WO1997046570A1 Oligoribonucleotides and ribonucleases for cleaving rna |
| 12/11/1997 | WO1997046551A1 Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors |
| 12/11/1997 | WO1997046547A1 β-SHEET NUCLEATING PEPTIDOMIMETICS |
| 12/11/1997 | WO1997046263A1 Il-12 gene therapy of tumors |
| 12/11/1997 | WO1997046259A2 Chimeric toxin for targeted therapy |
| 12/11/1997 | WO1997046257A1 A method for enhancing long-term memory in a subject and uses thereof |
| 12/11/1997 | WO1997046256A1 Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
| 12/11/1997 | WO1997046254A2 Reagents and methods for inhibiting cytokine release by blood cells |
| 12/11/1997 | WO1997046253A2 Immunotherapy for autoimmune disease |
| 12/11/1997 | WO1997046252A1 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis |